Biolidics Ltd. (SG:8YY) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Biolidics Limited has announced that due to financial challenges and an inability to secure new contracts, it is placing its subsidiary, Biomedics Laboratory Pte. Ltd., into creditors’ voluntary liquidation. The subsidiary, which specializes in PCR and medical laboratory testing services, has not been successful in generating revenue, leading to this decision. The liquidation is expected to reduce the Group’s net loss by approximately S$1.0 million for the financial year ending December 2024.
For further insights into SG:8YY stock, check out TipRanks’ Stock Analysis page.